INMED PHARMACEUTICALS INC (INM) Institutional Ownership Changes & 13F Activity
INMED PHARMACEUTICALS INC (INM). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Adar1 Capital Management, Llc, Vivo Capital, Llc, Squadron Capital Management Llc, Ikarian Capital, Llc, and Sabby Management, Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Sell | -20,889 | -44.5% | 26,084 | $40.43K | Q2 2026 | Sep 02, 2026 |
| Adar1 Capital Management, Llc | Buy | +800,000 | — | 800,000 | $1.24M | Q2 2026 | Aug 14, 2026 |
| Vivo Capital, Llc | Buy | +798,377 | — | 798,377 | $1.24M | Q2 2026 | Aug 14, 2026 |
| Squadron Capital Management Llc | Buy | +325,000 | — | 325,000 | $503.75K | Q2 2026 | Aug 14, 2026 |
| Ikarian Capital, Llc | Buy | +245,025 | — | 245,025 | $379.79K | Q2 2026 | Aug 14, 2026 |
| Sabby Management, Llc | Sell | -175,290 | -79.6% | 44,970 | $69.70K | Q2 2026 | Aug 14, 2026 |
| Ursa Fund Management, Llc | Buy | +125,800 | — | 125,800 | $194.99K | Q2 2026 | Aug 14, 2026 |
| Suvretta Capital Management, Llc | Buy | +100,000 | — | 100,000 | $155.00K | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Buy | +74,244 | — | 74,244 | $115.08K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +43,078 | — | 43,078 | $66.77K | Q2 2026 | Aug 14, 2026 |
| Venrock Adviser, Llc | Buy | +32,685 | — | 32,685 | $50.66K | Q2 2026 | Aug 14, 2026 |
| Seven Grand Managers, Llc | Buy | +25,000 | — | 25,000 | $38.75K | Q2 2026 | Aug 14, 2026 |
| Scientech Research Llc | Buy | +15,461 | — | 15,461 | $23.96K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Securities, Llc | Sell | -7,773 | -41.5% | 10,945 | $16.96K | Q2 2026 | Aug 14, 2026 |
| Stratos Wealth Partners, Ltd. | Buy | +10,760 | — | 10,760 | $16.68K | Q2 2026 | Aug 11, 2026 |
| Crestwood Advisors Group, Llc | Buy | +14,900 | — | 14,900 | $23.09K | Q2 2026 | Aug 03, 2026 |
| Virtu Financial Llc | Sell | -19,980 | -100.0% | 0 | $0.00 | Q2 2026 | May 14, 2026 |
| Ubs Group Ag | Sell | -8,068 | -100.0% | 0 | $0.00 | Q2 2026 | May 05, 2026 |
Frequently asked questions about INM activity
Which institutional owners are buying INM?
Institutional owners buying INM include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in INM activity?
"Buy" means an investor increased their reported position in INM compared to the prior reporting period. This reflects growing exposure to INMED PHARMACEUTICALS INC (INM) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in INM increasing?
Institutional interest in INM can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.